Open Society Supports an Innovative Model to Make Naloxone Easier to Access Amidst the U.S. Overdose Crisis

by C Tetro | Dec 12, 2023 | News

Narcan Now Available Over-the-counter – What to Know

by Jim Kelly | Sep 5, 2023 | News

Partnership to Save Lives: Harm Reduction Therapeutics to donate 200,000 RiVive™ naloxone doses to Remedy Alliance for free distribution

by C Tetro | Aug 17, 2023 | News

A new, cheaper naloxone is coming to pharmacy shelves, funded in part by Purdue Pharma’s bankruptcy

by Jim Kelly | Aug 17, 2023 | News

FDA APPROVAL OF RiVIVE™ IS A CRITICAL MILESTONE IN MAKING EMERGENCY TREATMENT OF OPIOID OVERDOSE MORE WIDELY AVAILABLE

by C Tetro | Aug 1, 2023 | News

Comparison of Administration of 8-Milligram and 4-Milligram Intranasal Naloxone by Law Enforcement During Response to Suspected Opioid Overdose

by C Tetro | Apr 11, 2023 | News

In 2021, an 8-mg intranasal naloxone product was approved by the Food and Drug Administration; however, no studies have examined outcomes among persons who receive the 8-mg naloxone product and those who receive the usual 4-mg product…